Knowledge, Attitude and Practice of Community Pharmacy Staffs Toward Pharmacovigilance and Reporting of Adverse Drug Reactions in Sulaimani City: A Cross Sectional Study
DOI:
https://doi.org/10.31351/vol34iss2pp29-39Keywords:
Attitude, Community Pharmacies, Knowledge, Pharmacovigilance, PracticeAbstract
Pharmacovigilance (PhV) is the science that is essential for detecting, preventing and reducing the adverse drug reactions (ADRs). Its main goal is to ensure the safety of post-marketing medications. This study is designed to determine the knowledge, attitude and practice of the pharmacy staffs (pharmacists and their assistants) toward PhV and ADRs reporting in the community pharmacies in Sulaimani City-Kurdistan Region-Iraq. The study designed as a cross-sectional face-to-face interview survey. A self-administered questionnaire was used in this study, the interviews were conducted from June to October 2022, a total of 141 pharmacists and their assistants in 60 community pharmacies were recruited for this study. The total number of responses was 131(93%). Basically, the finding of the current study revealed that more than half of the community pharmacy staffs were familiar to the term and aim of PhV. However, their knowledge on PhV and ADRs reporting was poor and inadequate. Generally, participants showed a positive attitude towards the aspects of PhV and ADRs reporting. 63.4% believed that the PhV is an important and essential element for safety of post-marketing medications. Despite this positive attitude, only 7.6% of the participants had previously reported an ADRs during their practice. 46.56% of the community pharmacists and their assistants stated that they were not-reporting ADRs because they were unmotivated. In conclusion, the majority of the pharmacy staffs were knowledgeable about the concepts of PhV and had agreed that reporting of ADR is necessary, but the reporting rate was very poor and inadequate. Integration of PhV in an interactive training course is needed to increase the awareness of ADRs reporting by healthcare professionals. Pharmacovigilance should also be taught in detail as a part of pharmacy undergraduate curriculum. Conducting workshops or courses to understand the reporting process is crucial to increase ADRs reporting.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
World Health Organization. The importance of pharmacovigilance. Published online 2002. https://apps.who.int/iris/handle/10665/42493
Hadi MA, Neoh CF, Zin RM, Elrggal M, Cheema E. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017;Volume 6:91-98. doi:10.2147/IPRP.S105881
Khalid Abbood M, Alaa Aldeen Khalaf H, H. Abudlqader E, Sagban Taghi H, Alaa Al-Temimi A. Scope of Pharmacovigilance: Comprehensive Review. Chem Sci Int J. Published online December 31, 2022:29-39. doi:10.9734/CSJI/2022/v31i5822
Routledge P. 150 years of pharmacovigilance. Lancet Lond Engl. 1998;351(9110):1200-1201. doi:10.1016/S0140-6736(98)03148-1
Fornasier G, Francescon S, Leone R, Baldo P. An historical overview over Pharmacovigilance. Int J Clin Pharm. 2018;40(4):744-747. doi:10.1007/s11096-018-0657-1
Plum P. [Congenital abnormalities and thalidomide]. Ugeskr Laeger. 1962;124:1227-1231.
Joseph MC. THALIDOMIDE AND CONGENITAL ABNORMALITIES. Dev Med Child Neurol. 2008;4(3):338-339. doi: 10. 1111 /j.1469-8749.1962.tb03179.x
Alshammari TM, Alenzi KA, Ata SI. National pharmacovigilance programs in Arab countries: A quantitative assessment study. Pharmacoepidemiol Drug Saf. 2020; 29(9): 1001 -1010. doi:10.1002/pds.4991
Alshammari TM, Mendi N, Alenzi KA, Alsowaida Y. Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries. Drug Saf. 2019;42(7):849-868. doi:10.1007/s40264-019-00807-4
Uppsala Reports January 2011 - PAHO/WHO | Pan American Health Organization. Accessed December 1, 2023. https:// www. paho. org/ en/documents/uppsala-reports-january-2011
Al-Jumaili AA, Younus MM, Kannan YJA, Nooruldeen ZE, Al-Nuseirat A. Pharmaceutical regulations in Iraq: from medicine approval to postmarketing. East Mediterr Health J. 2021; 27(10):1007-1015. doi:10.26719/emhj.21.025
B. Allela OQ, Elkalmi RM, Salih AS, Yousif DY, Ali HW, Shammo NO. Pharmacovigilance Knowledge and Perceptions Among Pharmacy, Medical and Nurse Students in University of Duhok. J Pharm Pract Community Med. 2018;4(2):60-65. doi:10.5530/jppcm.2018.2.16
Sandberg A, Salminen V, Heinonen S, Sivén M. Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals’ Perspectives on How to Improve Reporting. Healthcare. 2022;10(6):1015. doi:10.3390/healthcare10061015
Allela O. Explore Adverse Drug Reactions (ADRs) reporting by clinical and community pharmacists in Duhok, Kurdistan region- Iraq: hampered and perspective. Pharmacia. 2022;69(4):1057-1062. doi: 10. 3897 / pharmacia.69.e95691
Babar ZUD, Scahill SL. Pharmaceutical Policy. In: Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Elsevier; 2018:419-437. doi:10 .1016/ B978-0-12-811228-1.00025-X
Elfil M, Negida A. Sampling methods in Clinical Research; an Educational Review. Emerg Tehran Iran. 2017;5(1):e52.
Hussain R, Hassali MA, Hashmi F, Akram T. Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey. J Pharm Policy Pract. 2021;14(1):5. doi: 10. 1186 /s40545-020-00287-3
Jose J, Jimmy B, Al-Ghailani ASH, Al Majali MA. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Saudi Pharm J. 2014;22(2):163-169. doi:10.1016/j.jsps.2013.07.006
Al-Hazmi NN, Il N. A Study of Community Pharmacists? Awareness and Contributions to Adverse Drug Reactions (ADRs) Reporting Systems in the Makkah, Kingdom of Saudi Arabia (KSA). J Clin Trials. 2013;03(01). doi:10.4172/2167-0870.1000127
Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review. Drug Saf. 2013;36(5):317-328. doi:10.1007/s40264-013-0058-2
Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13-20. doi:10.1080/21556660.2019.1566137
Hutton A. Assessing Acquiescence in Surveys Using Positively and Negatively Worded Questions. VCU Libraries; 2017. doi:10.25772/GGVD-M636
AlShammari TM, Almoslem MJ. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study. Saudi Pharm J. 2018;26(7):925-931. doi:10.1016/j.jsps.2018.04.012
Alshabi AM, Shaikh MAK, Shaikh IA, Alkahtani SA, Aljadaan A. Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia. Saudi Pharm J. 2022;30(7):1018-1026. doi:10.1016/j.jsps.2022.04.014
Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J. 2017;25(6):830-837. doi:10.1016/j.jsps.2016.12.004
Suyagh M, Farah D, Abu Farha R. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015;23(2):147-153. doi:10.1016/j.jsps.2014.07.001
Sharrad A. Pharmacist’s knowledge, attitude and practice about adverse drug reaction in Basra/Iraq. Int J Pharm Sci Res. 2017;8(5):2309-2314.
Albayrak A, Karahali̇L B. Pharmacist’s Knowledge and Behaviors Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process in Türkiye. Turk J Pharm Sci. 2022;19(6):694-700. doi:10.4274/tjps.galenos.2022.59422
Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China: PHARMACISTS AND ADR REPORTING. Pharmacoepidemiol Drug Saf. 2010;19(3):217-222. doi:10.1002/pds.1792
Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556-562. doi:10.1007/s11096-008-9209-4
Abdel-Latif MMM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015;23(2):154-161. doi:10.1016/j.jsps.2014.07.005
Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci. 2009;31(2):183-187. doi:10.1007/s11096-008-9276-6
Mahmoud MA, Alswaida Y, Alshammari T, et al. Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J. 2014;22(5):411-418. doi:10.1016/j.jsps.2013.07.005
Wilbur K. Pharmacovigilance in the Middle East: A Survey of 13 Arabic-Speaking Countries. Drug Saf. 2013;36(1):25-30. doi:10.1007/s40264-012-0001-y
Bahnassi A, Al Harbi F. Syrian pharmacovigilance system: a survey of pharmacists’ knowledge, attitudes and practices. East Mediterr Health J. 2018;24(6):569-578. doi:10.26719/2018.24.6.569
Ali MD, Hassan YA, Ahmad A, Alaqel O, Al-Harbi H, Al-Suhaimi NM. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia. Curr Drug Saf. 2018;13(1):21-25. doi:10.2174/1574886313666171218123802
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
